Categories: Blog

Drug firms told to strengthen monitoring of medicine side effects

India’s drug regulator has mandated pharmaceutical companies to establish robust systems for tracking and reporting adverse drug reactions. This directive, stemming from Schedule M of the Drugs and Cosmetics Rules, reinforces the critical need for post-marketing surveillance to ensure patient safety. The move aligns with a global push for real-world safety data to identify rare or delayed side effects.

The News Vista

Leave a Comment
Share
Published by
The News Vista
4 months ago

Recent Posts

SIR row: Jantar Mantar entrance barricaded ahead of protests; Gaurav Gogoi, others detained in Assam

Across India, demonstrations erupted as citizens rallied for the resignation of chief election commissioner Gyanesh…

2 hours ago

What Is West Bengal’s ‘Anti-Goonda’ Bill That Didn’t Please President Droupadi Murmu? – Outlook India

What Is West Bengal’s ‘Anti-Goonda’ Bill That Didn’t Please President Droupadi Murmu?  Outlook India

2 hours ago

‘Dead mindset cannot see vibrancy’: Amit Shah hits back at Rahul’s ‘dead economy’ remark

2 hours ago

‘BrahMos made in UP giving Pakistan sleepless nights’: Amit Shah hails India’s growth ‘despite adversities’

3 hours ago

Disqualified over footwear! Iran’s Fatemeh out of heptathlon in dramatic setback

Fatemeh Mohitizadeh from Iran experienced disqualification at the Asian Games 2026 during the women's heptathlon…

3 hours ago

23 Himveers battle weeks of gruelling Himalayan climbing to reach 24,131-ft Mt Abi Gamin & unfurl Tricolour

At more than 7,000 metres, Abi Gamin presents a combination of thin air, freezing temperatures,…

3 hours ago